OF NEXALIN TECHNOLOGY
Clears FDA for the treatment of Anxiety, Depression and Insomnia. Nexalin is presently analyzing prior FDA applications to determine new regulatory strategies for the treatment of Insomnia.
Nexalin begins analyzing 510K application process for Anxiety and Insomnia (postpones Depression PMA)
Nexalin develops and begins research on the China A,D (Alzheimer's and Dementia)
Nexalin develops the Nexalin Gen-2 medical device and begins research with new advanced waveform
Nexalin approved by China NMPA for treatment of Depression and Insomnia
Nexalin’s Gen-3 technology will be imbedded into a new patient headset medical device. Image is a prototype image.